Matthew Law

发表

Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study.

Peter Reiss, Ole Kirk, Eric Fontas, 2018, The lancet. HIV.

Effectiveness of needle and syringe programmes for preventing HIV transmission

John M. Kaldor, J. Kaldor, G. Dore, 2003 .

Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells.

Christof von Kalle, Roger Garsia, Robert Finlayson, 2009, Nature medicine.

A randomized, double-blind study of gemfibrozil for the treatment of protease inhibitor-associated hypertriglyceridaemia

Dannae Brown, J. Kaldor, D. Cooper, 2002, AIDS.

Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons.

Jacques Fellay, Amalio Telenti, Huldrych F Günthard, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Quilt Plots: A Simple Tool for the Visualisation of Large Epidemiological Data

Lisa Maher, Handan Wand, H. Wand, 2014, PloS one.

Dynamics of T Cells and TCR Excision Circles Differ After Treatment of Acute and Chronic HIV Infection1 2

Alan S. Perelson, Ruy M. Ribeiro, John Zaunders, 2002, The Journal of Immunology.

Effect estimates in randomized trials and observational studies: comparing apples with apples.

Haitao Chu, Kholoud Porter, Stephen R Cole, 2019, American journal of epidemiology.

The Impact of Needle and Syringe Programs on HIV and HCV Transmissions in Injecting Drug Users in Australia: A Model-Based Analysis

Lisa Maher, David P. Wilson, Jisoo A. Kwon, 2009, Journal of acquired immune deficiency syndromes.

Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: patient characteristics and patterns and predictors of treatment retention.

Louisa Degenhardt, Lucy Burns, Tony Butler, 2009, Addiction.

The per-protocol effect of immediate versus deferred antiretroviral therapy initiation

Haitao Chu, Stephen R Cole, Roger Logan, 2016, AIDS.

Plasma levels of soluble CD14 independently predict mortality in HIV infection.

Handan Wand, Sean Emery, Daniel E Nixon, 2011, The Journal of infectious diseases.

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

David A. Cooper, D. Cooper, D. Chisholm, 1998, AIDS.